Patents by Inventor Zeynep Ates-Alagoz

Zeynep Ates-Alagoz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180280319
    Abstract: The present invention provides novel methods of treating triple-negative breast cancer (TNBC). In certain embodiments, the methods of the invention do not require the use of ionizing radiation therapies. In other embodiments, the methods of the invention do not harm non-cancerous cells.
    Type: Application
    Filed: April 4, 2018
    Publication date: October 4, 2018
    Inventors: ADEBOYE ADEJARE, ISABELLE MERCIER, ZEYNEP ATES-ALAGOZ
  • Patent number: 8735590
    Abstract: The present invention provides bicyclo-heptan-2-amines that selectively bind to the sigma-2 receptor and are useful in the treatment of diseases related to the sigma-2 receptor, for example, cancer and neurological disorders.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: May 27, 2014
    Inventors: Adeboye Adejare, Zeynep Ates-Alagoz, Boyenoh Gaye
  • Publication number: 20120190710
    Abstract: The present invention provides bicyclo-heptan-2-amines that selectively bind to the sigma-2 receptor and are useful in the treatment of diseases related to the sigma-2 receptor, for example, cancer and neurological disorders.
    Type: Application
    Filed: January 20, 2012
    Publication date: July 26, 2012
    Applicant: Adeboye Adejare
    Inventors: Adeboye Adejare, Zeynep Ates-Alagoz, Boyenoh Gaye